baCta funding news – Paris-based baCta secures €3.3 Million in Pre Seed Funding

baCta benefits from the guidance of top scientists like Pr. Ariel Lindner, Pr. Pablo Nikel, and Dr. Steffen Lindner-Mehlich, in addition to seasoned biotech entrepreneurs like Dan Windmaier, founder of Bolt Threads (Nasdaq: BSLK).

Prominent scientists including Dr. Steffen Lindner-Mehlich (Charité – Universitätsmedizin Berlin), Pr. Ariel Lindner (INSERM, Université Paris Cité), and Pr. Pablo Nikel (DTU University) advise the startup, in addition to seasoned biotech founders like Dan Windmaier (Nasdaq:BSLK).

A vital raw element, natural rubber has a 40 billion dollar industry. The petrochemical sector provides half of the global supply, with the remaining half coming from the cultivation of Hevea rubber trees, whose exploitation results in significant deforestation and puts them in danger from climate change.

Read also - Harmonic Security funding news – London-based Harmonic Security Raises $17.5Million in Series A Round Funding

BaCta's innovative technology makes use of a platform for synthetic organelles created at INSERM and the capacity to diversify feedstock sources in order to reduce costs and achieve a carbon footprint that is zero. Additionally, they utilise the most recent developments in AI, protein modelling, and lab automation to gather proprietary data at a never-before-seen rate and process it to model organisms and bioreactors, enabling industrial bio-production.

Mathieu Nohet Founder and CEO of baCta said, “This funding marks a significant step forward in our mission to decarbonize the rubber industry, It is a crucial raw material, present everywhere in our daily lives, for which we don’t have a clean alternative. We are excited to partner with investors who share our commitment to sustainable abundance and our vision of microbes as programmable molecular factories.”

The money will go towards supporting research, growing the team—scientists from prestigious universities and biotech firms have already been hired—and boosting output.

Augustin Sayer, OVNI Capital said, “Western economies have been overly dependent on other countries for strategic materials, which exposes vulnerabilities in our industrial supply chain. Synthetic Biology offers a promising solution for creating sustainable and abundant resources,”.

Falk Haurenherm, another.vc said, “We are excited to invest in baCta because of their outstanding team, which uniquely combines strong ambition, commitment to sustainability, along with complementary skills in synthetic biology, entrepreneurship, and industrialization. Producing isoprenoids profitably in E. coli is a breakthrough with immense industrial and environmental potential,”.

About BaCta

BaCta, which was founded in January 2024 by Mathieu Nohet (former founder of Manty), Marie Rouquette (former senior project manager at Eligo Bioscience), and Selcuk Aslan (former team lead at Neoplants), uses genetically modified microorganisms and renewable feedstocks to produce high-quality, carbon-negative natural rubber.